Breaking:

MD Anderson - MD Anderson Cancer Center | BioNews Texas

Sort posts

“Father of Tamoxifen” V. Craig Jordan Brings His Translational Research Expertise To MD Anderson Cancer Center

“Father of Tamoxifen” V. Craig Jordan Brings His Translational Research Expertise To MD Anderson Cancer Center

Breast cancer research pioneer, one of the world’s most respected experts in breast cancer research and treatment, and developer of several cancer-fighting drugs Virgil Craig Jordan, OBE, PhD, DSc, will be joining Houston’s University of Texas MD Anderson Cancer Center this fall. Dr. Jordan, who was born in New Braunfels, Texas and raised in England, holds dual British and U.S. citizenship, ...

Read More »

MD Anderson Ranked Second Best Hospital in Cancer Care by Annual National Report

MD Anderson Ranked Second Best Hospital in Cancer Care by Annual National Report

University of Texas MD Anderson Cancer Center was ranked second in the annual “Best Hospitals” survey conducted by U.S. News & World Report, maintaining its tradition of remaining in the top two positions in the category of best hospitals for cancer care. Over the last 13 years, the cancer center has been ranked first ten times, but this year the first-place award ...

Read More »

New MD Anderson Research Questions Early Prostate Cancer Treatment Options

New MD Anderson Research Questions Early Prostate Cancer Treatment Options

Researchers at The University of Texas MD Anderson Cancer Center recently published their latest findings on the role a diagnosing urologist plays in deciding whether older men with low-risk prostate cancer should receive treatment for their disease, and consequently the type of treatment they receive. Prostate cancer is the most common non-skin cancer in men, with 233,000 new cases being diagnosed every ...

Read More »

New Route For Ovarian Cancer Spread Uncovered By MD Anderson Researchers

New Route For Ovarian Cancer Spread Uncovered By MD Anderson Researchers

A team of scientists at The University of Texas MD Anderson Cancer Center has published their latest research results in Cancer Cell, showing that circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue, the omentum, where it can grow and metastasize to other organs. The researchers used a parabiosis mouse model, ...

Read More »

MD Anderson Oncology Director Favors Morcellators in Heated Debate

MD Anderson Oncology Director Favors Morcellators in Heated Debate

On the forefront of a heated debate concerning laparoscopic power morcellators (LPMs) in uterine fibroid surgery is Jubilee Brown, MD, Director of Oncology at the University of Texas MD Anderson Cancer Center. Dr. Jubilee Brown is in favor of LPMs used for minimally invasive surgery to remove fibrous growths from the uterus of affected women. According to Dr. Brown, findings ...

Read More »

MolecularHealth’s Personalized Cancer System Impresses at International Conference

MolecularHealth’s Personalized Cancer System Impresses at International Conference

Biomedical company MolecularHealth‘s personalized TreatmentMAP technology for cancer patients was recently the main theme of the annual Hauptstadtkongress conference in Berlin, and reportedly impressed the medical community. With a CLIA-certified NGS lab located in Woodlands, Texas, the development of the system included collaboration from the University of Texas MD Anderson Cancer Center. The CEO of MolecularHealth, Dr. Stephan Brock, stated that, “the classification of evidence ...

Read More »

T-Cells Manipulated by “Sleeping Beauty” to Attack Cancers at MD Anderson

T-Cells Manipulated by “Sleeping Beauty” to Attack Cancers at MD Anderson

Real-life Sleeping Beauty is being used for the first time to combat fungal infections and improve leukemia and lymphoma treatment in the laboratory of Laurence Cooper, MD, PhD, at The University of Texas MD Anderson Cancer Center. Dr. Cooper’s study, authored by a number of researchers at MD Anderson and The University of Texas Graduate School of Biomedical Sciences, was ...

Read More »

Designer Cells Used To Prevent Fungal Infections in Cancer Patients

Designer Cells Used To Prevent Fungal Infections in Cancer Patients

The incidence of fungal infections, especially those caused by Aspergilllus, has been on the rise in cancer patients. Treatments to combat cancer results in reduced immunity in patients, making them more susceptible to infections. The efficacy of antifungal agents has diminished over the decades, making it necessary to find new ways to combat these potentially fatal pathogens. To address this growing need, researchers ...

Read More »

MD Anderson, BCM and UTHealth Study Uses Pseudogenes as Cancer Biomarkers

MD Anderson, BCM and UTHealth Study Uses Pseudogenes as Cancer Biomarkers

New research from University of Texas MD Anderson Cancer Center is shining light on pseudogenes to determine their utility as cancer biomarkers. Bioinformatics and Computational Biology Professor Han Liang, PhD, recently published a study in Nature Communications that analyzed nearly 10,000 pseudogenes to better understand biomarkers. “The study surveyed seven cancer subtypes including those for breast, kidney, ovarian, colorectal, lung, and ...

Read More »

Obesity Elevates Risk of Breast Cancer in Women, According To New MD Anderson Study

Obesity Elevates Risk of Breast Cancer in Women, According To New MD Anderson Study

Nearly 1 million women worldwide are diagnosed with breast cancer on a yearly basis, with a large majority of them being postmenopausal. This tends to be the age when women gain significant body weight. After age and family history, obesity and its associated increase in estrogen levels seems to correlate with an increased incidence and higher risk of death from breast cancer in ...

Read More »

MD Anderson’s Diane Barber Wins 2014 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award

MD Anderson’s Diane Barber Wins 2014 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award

MD Anderson Cancer Center nurse Diane Barber, Ph.D., was awarded the 2014 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award for her work in Investigational Cancer Therapeutics (ICT), Phase I Clinical Trials Program. The prize, established in 1982 by The Brown Foundation, Inc., is considered to be the institution’s highest honor in nursing. Barber has been a nurse for 26 years, arriving at ...

Read More »

Iris BioTechnologies Announces Plan To Create Personalized Precision Medicine Platform

Iris BioTechnologies Announces Plan To Create Personalized Precision Medicine Platform

Life sciences company Iris Biotechnologies recently announced a new technology platform aimed at determining the most appropriate treatment for cancer or other diseases at this year’s BIO International, a major biotech conference and exhibition that brought together 15,000 professionals from 4,000 organizations in 65 countries as well as representatives from at least seven innovative companies located within the Texas Biocorridor. The company works ...

Read More »

MD Anderson Genomics Chair Lynda Chin Nominated Chancellor’s Health Fellow, Will Take On Diabetes Management In South Texas Using Big Data

MD Anderson Genomics Chair Lynda Chin Nominated Chancellor’s Health Fellow, Will Take On Diabetes Management In South Texas Using Big Data

Lynda Chin, M.D., current chair of Genomic Medicine at University of Texas (UT) MD Anderson was recently nominated as a UT System Chancellor’s Health Fellow, and will coordinate planning and development of a collaborative effort for improving healthcare delivery through the use of technology and big data. The main focus of Dr. Chin’s project will be the management of diabetes in the ...

Read More »

MD Anderson President DePinho Co-Lead Author On New Study Into Pancreatic Cancer Resistance

MD Anderson President DePinho Co-Lead Author On New Study Into Pancreatic Cancer Resistance

University of Texas MD Anderson Cancer Center President Ron DePinho, MD, along with two other lead co-authors, recently discovered a mechanism for pancreatic cancer resistance and reported their findings in Cell. “Pancreas cancer remains an intractable disease with limited therapeutic options,” said Dr. DePinho, who also serves as a professor of Cancer Biology at MD Anderson, in a news release. ...

Read More »

Immunologists Allison and Honjo Share Tang Prize For Their Research On Cancer

Immunologists Allison and Honjo Share Tang Prize For Their Research On Cancer

Immunologists James P. Allison, Chair of Immunology at MD Anderson Cancer Center and Tasuku Honjo of Kyoto University were awarded the Tang Prize in the biopharmaceutical sciences’ category for their groundbreaking cancer related discoveries. Both scientists have dedicated their research to the study of immunology — the capacity of our immune system to fight infections and diseases on its own — and to the understanding of ...

Read More »

MD Anderson Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment

MD Anderson Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel lymph node (SLN) biopsy, a minimally invasive technique, which has become the standard surgical procedure. Further findings of this study ...

Read More »

DNAtrix Drug For Recurrent Glioblastoma Receives Fast Track FDA Status

DNAtrix Drug For Recurrent Glioblastoma Receives Fast Track FDA Status

DNAtrix, a Houston-based company focused on several cancer indications, including recurrent glioblastoma, was granted Fast Track status by the U.S. Food and Drug Administration (FDA) for DNX-2401, a replication-competent adenovirus that has been studied for more than a decade at the University of Texas MD Anderson Cancer Center. The FDA Fast Track status facilitates the development of new products that the FDA believes have potential ...

Read More »

Needle Biopsy Underuse in Breast Cancer Diagnosis Has Negative Impact on Diagnosis and Treatment

Needle Biopsy Underuse in Breast Cancer Diagnosis Has Negative Impact on Diagnosis and Treatment

Needle biopsy is underused as the standard radiological procure of care for the diagnosis of breast cancer, while patients are receiving more invasive, surgical biopsy procedures. These are the conclusions of new research from the University of Texas MD Anderson Cancer Center, recently published in the Journal of Clinical Oncology. According to the study, patients are encouraged by surgeons to ...

Read More »

Statins Combined with Radiation May Reduce Recurrence of Inflammatory Breast Cancer

Statins Combined with Radiation May Reduce Recurrence of Inflammatory Breast Cancer

Patients with inflammatory breast cancer (IBC) could benefit from combining radiation with simvastatin, a generic, low-cost medication typically prescribed to treat high cholesterol. The novel treatment option was recently suggested in a new study conducted at the University of Texas MD Anderson Cancer Center, in Houston, published in Stem Cells Translational Medicine, and led by Wendy Woodward, M.D., Ph.D. and Lara Lacerda, PharmD, ...

Read More »

Metastatic Breast Cancer Can Safely Be Treated Less Frequently With Bisphosphonates, MD Anderson

Metastatic Breast Cancer Can Safely Be Treated Less Frequently With Bisphosphonates, MD Anderson

University of Texas MD Anderson Cancer Center researchers proved that women with metastatic breast cancer that spreads to the bone can be treated with a smaller dosage of bisphosphonates after the first year of monthly administration. Changes in the treatment with this bone-targeting class of drugs, such as zoledronic acid, can reduce the risk of serious side effects. The study OPTIMIZE-2, ...

Read More »

MD Anderson Begins Testing Immunotherapy Drugs On Early-Stage Brain Tumor Patients

MD Anderson Begins Testing Immunotherapy Drugs On Early-Stage Brain Tumor Patients

University of Texas MD Anderson Cancer Center researchers are about to start testing two immunotherapy drugs developed by the Bristol-Myers Squibb Company. The experimental drugs are expected to offer a new treatment option for brain tumors known as glioblastomas. The tests will be performed in newly diagnosed patients with glioblastomas, which is the most common form of deadly brain cancer in ...

Read More »

ASCO Hails MD Anderson Leaders For Their Contributions To Cancer Research

ASCO Hails MD Anderson Leaders For Their Contributions To Cancer Research

Former MD Anderson president John Mendelsohn, M.D., Waun Ki Hong, M.D., who was recently featured on BioNews Texas, and Gabriel Hortobagyi, M.D., have been named to the American Society of Clinical Oncology (ASCO), as the organization celebrates its 50th anniversary for outstanding achievements in the areas of cancer research and treatment. Mendelsohn presided over The University of Texas MD Anderson Cancer Center between 1996 and ...

Read More »

New Scientific Studies At ASCO Could Revolutionize the Treatment of Resistant Cancers

New Scientific Studies At ASCO Could Revolutionize the Treatment of Resistant Cancers

Four clinical trials for investigational cancer therapies have shown positive results in combating advanced ovarian, lung, and thyroid cancers, as well as chronic lymphocytic leukemia. The results, which were presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), have increased researchers’ hope for finding ways to slow down disease progression and improve survival rates. “Cancer ...

Read More »

MD Anderson Researcher Reveals Correlation Between Oncogene Mutation Signal in Urinary Cell Free DNA and Treatment Response

MD Anderson Researcher Reveals Correlation Between Oncogene Mutation Signal in Urinary Cell Free DNA and Treatment Response

A University of Texas MD Anderson Cancer Center researcher recently revealed oncogene mutation load in urinary cell-free DNA is significantly correlated with treatment course, according to a study conducted in partnership with Trovagene, a San Diego, CA based biotech firm seeking to improve cancer treatment with technology that detects cell-free DNA and RNA. Filip Janku, M.D., Ph.D. studied multiple sequential ...

Read More »
Scroll To Top
Close